Webinar

From regulation to reformulation: managing the MIT phase-out in european home care

The LANXESS webinar delivers a concise overview of the European regulatory drivers behind the future of MIT in home care applications, followed by a focused technical discussion on suitable preservation alternatives. Attendees will gain practical insights into regulatory compliance, performance considerations, and reformulation strategies that support both short-term transition and long-term regulatory resilience.

Date

26/03/2026

Start Time

11:00

Finish Time

11:35

Melanie Keck, Natacha Cadenne-Feuillette, Vivien Konetzky

LANXESS

Register Now
Lanxess_HC_webinar_2026_hero
Lanxess_HC_webinar_2026_hero

The recent decisions applicable to methylisothiazolinone (MIT) in European consumer applications are reshaping preservation strategies across the home care sector. Driven by evolving regulatory expectations, including restrictions under the European Biocidal Products Regulation (BPR) and increasing scrutiny of sensitizing substances, formulators and compliance teams are facing growing pressure to reformulate while maintaining product safety, performance, and shelf life.

This could also be interesting for you

Lanxess_Home care_Hero
Lanxess_Home care_Hero

LANXESS for Home Care

LANXESS brings robust preservation, hygiene, and performance technologies to the home care sector.